FDA Approved Pluvicto Plus ARPI for PSMA-Positive mAPMN/S Prostate Cancer
AstraZeneca-Bristol Myers Merger Denied: What It Exposed
FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer
Community Oncologists: Bringing Cancer Care Closer, Smarter, and Stronger
E. Anders Kolb։ Protecting the Integrity of the Scientific Review Process
Can Diet and the Gut Microbiome Improve Immunotherapy Response?
Early Detection Gains Cannot Be Won Alone: Kenya's Journey Toward Cervical Cancer Elimination Through Partnership
Immunotherapy in Algeria: A Major Advance in Cancer Care
